The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Ataluren API Market Research Report 2025
Synopsis
It is a medication for the treatment of Duchenne muscular dystrophy.
Global Ataluren API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ataluren API market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ataluren API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Crystal Pharma
Fabbrica
Synthonix
MedChemexpress
Cckinase
Biosynth
BOC Sciences
ApexBio Technology
Alchem Pharmtech
AdooQ BioScience
Segment by Type
＞98%
＞99%
Segment by Application
Adult
Child
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Ataluren API report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
It is a medication for the treatment of Duchenne muscular dystrophy.
Global Ataluren API market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Ataluren API market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Ataluren API market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Crystal Pharma
Fabbrica
Synthonix
MedChemexpress
Cckinase
Biosynth
BOC Sciences
ApexBio Technology
Alchem Pharmtech
AdooQ BioScience
Segment by Type
＞98%
＞99%
Segment by Application
Adult
Child
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
The Ataluren API report covers below items:
Chapter 1: Product Basic Information (Definition, type and application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Production Region Distribution and Analysis
Chapter 4: Country Level Sales Analysis
Chapter 5: Product Type Analysis
Chapter 6: Product Application Analysis
Chapter 7: Manufacturers’ Outline
Chapter 8: Industry Chain, Market Channel and Customer Analysis
Chapter 9: Market Opportunities and Challenges
Chapter 10: Market Conclusions
Chapter 11: Research Methodology and Data Source
Index1 Ataluren API Market Overview
1.1 Product Definition
1.2 Ataluren API Segment by Type
1.2.1 Global Ataluren API Market Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 ＞98%
1.2.3 ＞99%
1.3 Ataluren API Segment by Application
1.3.1 Global Ataluren API Market Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Adult
1.3.3 Child
1.4 Global Market Growth Prospects
1.4.1 Global Ataluren API Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Ataluren API Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Ataluren API Production Estimates and Forecasts (2018-2029)
1.4.4 Global Ataluren API Market Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Ataluren API Production Market Share by Manufacturers (2018-2023)
2.2 Global Ataluren API Production Value Market Share by Manufacturers (2018-2023)
2.3 Global Key Players of Ataluren API, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Ataluren API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Ataluren API Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Ataluren API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Ataluren API, Product Offered and Application
2.8 Global Key Manufacturers of Ataluren API, Date of Enter into This Industry
2.9 Ataluren API Market Competitive Situation and Trends
2.9.1 Ataluren API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Ataluren API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Ataluren API Production by Region
3.1 Global Ataluren API Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Ataluren API Production Value by Region (2018-2029)
3.2.1 Global Ataluren API Production Value Market Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Ataluren API by Region (2024-2029)
3.3 Global Ataluren API Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Ataluren API Production by Region (2018-2029)
3.4.1 Global Ataluren API Production Market Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Ataluren API by Region (2024-2029)
3.5 Global Ataluren API Market Price Analysis by Region (2018-2023)
3.6 Global Ataluren API Production and Value, Year-over-Year Growth
3.6.1 North America Ataluren API Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Ataluren API Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Ataluren API Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Ataluren API Production Value Estimates and Forecasts (2018-2029)
4 Ataluren API Consumption by Region
4.1 Global Ataluren API Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Ataluren API Consumption by Region (2018-2029)
4.2.1 Global Ataluren API Consumption by Region (2018-2023)
4.2.2 Global Ataluren API Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Ataluren API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Ataluren API Consumption by Country (2018-2029)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Ataluren API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Ataluren API Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Ataluren API Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Ataluren API Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Ataluren API Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Ataluren API Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Ataluren API Production by Type (2018-2029)
5.1.1 Global Ataluren API Production by Type (2018-2023)
5.1.2 Global Ataluren API Production by Type (2024-2029)
5.1.3 Global Ataluren API Production Market Share by Type (2018-2029)
5.2 Global Ataluren API Production Value by Type (2018-2029)
5.2.1 Global Ataluren API Production Value by Type (2018-2023)
5.2.2 Global Ataluren API Production Value by Type (2024-2029)
5.2.3 Global Ataluren API Production Value Market Share by Type (2018-2029)
5.3 Global Ataluren API Price by Type (2018-2029)
6 Segment by Application
6.1 Global Ataluren API Production by Application (2018-2029)
6.1.1 Global Ataluren API Production by Application (2018-2023)
6.1.2 Global Ataluren API Production by Application (2024-2029)
6.1.3 Global Ataluren API Production Market Share by Application (2018-2029)
6.2 Global Ataluren API Production Value by Application (2018-2029)
6.2.1 Global Ataluren API Production Value by Application (2018-2023)
6.2.2 Global Ataluren API Production Value by Application (2024-2029)
6.2.3 Global Ataluren API Production Value Market Share by Application (2018-2029)
6.3 Global Ataluren API Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Crystal Pharma
7.1.1 Crystal Pharma Ataluren API Corporation Information
7.1.2 Crystal Pharma Ataluren API Product Portfolio
7.1.3 Crystal Pharma Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Crystal Pharma Main Business and Markets Served
7.1.5 Crystal Pharma Recent Developments/Updates
7.2 Fabbrica
7.2.1 Fabbrica Ataluren API Corporation Information
7.2.2 Fabbrica Ataluren API Product Portfolio
7.2.3 Fabbrica Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Fabbrica Main Business and Markets Served
7.2.5 Fabbrica Recent Developments/Updates
7.3 Synthonix
7.3.1 Synthonix Ataluren API Corporation Information
7.3.2 Synthonix Ataluren API Product Portfolio
7.3.3 Synthonix Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Synthonix Main Business and Markets Served
7.3.5 Synthonix Recent Developments/Updates
7.4 MedChemexpress
7.4.1 MedChemexpress Ataluren API Corporation Information
7.4.2 MedChemexpress Ataluren API Product Portfolio
7.4.3 MedChemexpress Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.4.4 MedChemexpress Main Business and Markets Served
7.4.5 MedChemexpress Recent Developments/Updates
7.5 Cckinase
7.5.1 Cckinase Ataluren API Corporation Information
7.5.2 Cckinase Ataluren API Product Portfolio
7.5.3 Cckinase Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Cckinase Main Business and Markets Served
7.5.5 Cckinase Recent Developments/Updates
7.6 Biosynth
7.6.1 Biosynth Ataluren API Corporation Information
7.6.2 Biosynth Ataluren API Product Portfolio
7.6.3 Biosynth Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Biosynth Main Business and Markets Served
7.6.5 Biosynth Recent Developments/Updates
7.7 BOC Sciences
7.7.1 BOC Sciences Ataluren API Corporation Information
7.7.2 BOC Sciences Ataluren API Product Portfolio
7.7.3 BOC Sciences Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.7.4 BOC Sciences Main Business and Markets Served
7.7.5 BOC Sciences Recent Developments/Updates
7.8 ApexBio Technology
7.8.1 ApexBio Technology Ataluren API Corporation Information
7.8.2 ApexBio Technology Ataluren API Product Portfolio
7.8.3 ApexBio Technology Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.8.4 ApexBio Technology Main Business and Markets Served
7.7.5 ApexBio Technology Recent Developments/Updates
7.9 Alchem Pharmtech
7.9.1 Alchem Pharmtech Ataluren API Corporation Information
7.9.2 Alchem Pharmtech Ataluren API Product Portfolio
7.9.3 Alchem Pharmtech Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Alchem Pharmtech Main Business and Markets Served
7.9.5 Alchem Pharmtech Recent Developments/Updates
7.10 AdooQ BioScience
7.10.1 AdooQ BioScience Ataluren API Corporation Information
7.10.2 AdooQ BioScience Ataluren API Product Portfolio
7.10.3 AdooQ BioScience Ataluren API Production, Value, Price and Gross Margin (2018-2023)
7.10.4 AdooQ BioScience Main Business and Markets Served
7.10.5 AdooQ BioScience Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Ataluren API Industry Chain Analysis
8.2 Ataluren API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Ataluren API Production Mode & Process
8.4 Ataluren API Sales and Marketing
8.4.1 Ataluren API Sales Channels
8.4.2 Ataluren API Distributors
8.5 Ataluren API Customers
9 Ataluren API Market Dynamics
9.1 Ataluren API Industry Trends
9.2 Ataluren API Market Drivers
9.3 Ataluren API Market Challenges
9.4 Ataluren API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
